Hirotoshi Matsui

3.5k total citations
107 papers, 2.4k citations indexed

About

Hirotoshi Matsui is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, Hirotoshi Matsui has authored 107 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 37 papers in Infectious Diseases and 31 papers in Epidemiology. Recurrent topics in Hirotoshi Matsui's work include Tuberculosis Research and Epidemiology (19 papers), Mycobacterium research and diagnosis (18 papers) and Tracheal and airway disorders (14 papers). Hirotoshi Matsui is often cited by papers focused on Tuberculosis Research and Epidemiology (19 papers), Mycobacterium research and diagnosis (18 papers) and Tracheal and airway disorders (14 papers). Hirotoshi Matsui collaborates with scholars based in Japan, United States and Italy. Hirotoshi Matsui's co-authors include Richard C. Boucher, Scott H. Randell, C. William Davis, S. Peretti, Hideaki Nagai, Douglas M. McCarty, Raymond J. Pickles, Pádraig Hart, Takahide Nagase and Larry G. Johnson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Hirotoshi Matsui

101 papers receiving 2.4k citations

Peers

Countries citing papers authored by Hirotoshi Matsui

Since Specialization

Citations

This map shows the geographic impact of Hirotoshi Matsui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirotoshi Matsui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirotoshi Matsui more than expected).

Fields of papers citing papers by Hirotoshi Matsui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirotoshi Matsui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirotoshi Matsui. The network helps show where Hirotoshi Matsui may publish in the future.

Co-authorship network of co-authors of Hirotoshi Matsui

This figure shows the co-authorship network connecting the top 25 collaborators of Hirotoshi Matsui. A scholar is included among the top collaborators of Hirotoshi Matsui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirotoshi Matsui. Hirotoshi Matsui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Case of Chronic Cavitary Pulmonary Schizophyllum Commune Infection With Fungal Ball Formation 2024 ·Tomohiko Kato, (unknown), Takeshi Fukami, Masashi Kitani, Akira Hebisawa, Junko Suzuki, Akira Watanabe, Nobuharu Ohshima, Yoshiteru Morio, Hirotoshi Matsui	0
2	Differences in asthma-related outcomes by anti-IL-5 biologics, omalizumab, and dupilumab based on blood eosinophil counts 2024 ·Asian Pacific Journal of Allergy and Immunology ·(unknown), Maho Suzukawa, (unknown), Shinobu Imai, Hiromasa Horiguchi, Manabu Akazawa, Hirotoshi Matsui	1
3	Serum total IgE may be a biomarker among chronic pulmonary aspergillosis patients with elevated serum total IgE levels: A cohort study with pathological evaluations 2022 ·Medical Mycology ·(unknown), Junko Suzuki, Maho Suzukawa, Keita Takeda, (unknown), Masashi Kitani, Takeshi Fukami, Yuka Sasaki, Akira Hebisawa, Hirotoshi Matsui	8
4	Prognostic factors of chronic pulmonary aspergillosis: A retrospective cohort of 264 patients from Japan 2021 ·PLoS ONE ·(unknown), Yuka Sasaki, Junko Suzuki, Jun Suzuki, (unknown), Maho Suzukawa, Hirotoshi Matsui	17
5	Migrated coil expectorated 12 years after embolization of pulmonary arteriovenous malformation, due probably to abscess formation around the coil 2020 ·Respiratory Medicine Case Reports ·A Konno, Shota Yamamoto, Junko Suzuki, Takeshi Fukami, Masashi Kitani, Hirotoshi Matsui	4
6	A case of Mycobacterium tuberculosis laboratory cross-contamination 2019 ·Journal of Infection and Chemotherapy ·Keita Takeda, Yoshiro Murase, Masahiro Kawashima, Maho Suzukawa, Junko Suzuki, Akira Yamane, Yuriko Igarashi, Kinuyo Chikamatsu, Yuta Morishige, Akio Aono, Hiroyuki Yamada, Akiko Takaki, Atsuhisa Tamura, Hideaki Nagai, Hirotoshi Matsui, Shigeto Tohma, Satoshi Mitarai	4
7	The benefit of stool mycobacterial examination to diagnose pulmonary tuberculosis for adult and elderly patients 2019 ·Journal of Clinical Tuberculosis and Other Mycobacterial Diseases ·A Konno, Osamu Narumoto, Hirotoshi Matsui, Keita Takeda, (unknown), (unknown), Hiroyuki Tashimo, Masahiro Kawashima, Akira Yamane, Atsuhisa Tamura, Hideaki Nagai, Ken Ohta, Shigeto Tohma	4
8	Localization of Secretory Mucins MUC5AC and MUC5B in Normal/Healthy Human Airways 2018 ·American Journal of Respiratory and Critical Care Medicine ·Kenichi Okuda, Gang Chen, Durai B. Subramani, (unknown), Rodney C. Gilmore, Takafumi Kato, Giorgia Radicioni, Mehmet Kesımer, Michael Chua, Hong Dang, Alessandra Livraghi-Butrico, Camille Ehré, Claire M. Doerschuk, Scott H. Randell, Hirotoshi Matsui, Takahide Nagase, Wanda K. O’Neal, Richard C. Boucher	169
9	Clinical and Angiographic Characteristics of 35 Patients With Cryptogenic Hemoptysis 2017 ·CHEST Journal ·Takahiro Ando, Masahiro Kawashima, Kimihiko Masuda, Keita Takeda, Kenichi Okuda, Junko Suzuki, Nobuharu Ohshima, Hirotoshi Matsui, Atsuhisa Tamura, Hideaki Nagai, Shinobu Akagawa, Ken Ohta	21
10	Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy 2015 ·Respiratory Medicine ·Kazuya Koyama, Nobuharu Ohshima, Masahiro Kawashima, Kenichi Okuda, Ryota Sato, Hideaki Nagai, Hirotoshi Matsui, Ken Ohta	4
11	Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease 2015 ·BMC Infectious Diseases ·Tsukasa Kadota, Hirotoshi Matsui, Takashi Hirose, Junko Suzuki, Minako Saito, (unknown), Kouichi Kobayashi, (unknown), Masahiro Kawashima, Atsuhisa Tamura, Hideaki Nagai, Shinobu Akagawa, Nobuyuki Kobayashi, Ken Ohta	41
12	Chronic Thromboembolic Pulmonary Hypertension Complicated by a Cavitating Lung Infection Caused by <i>Mycobacterium intracellulare</i> 2014 ·Internal Medicine ·Kenichi Okuda, Hirotoshi Matsui, Junko Suzuki, Nobuharu Ohshima, Kimihiko Masuda, Akira Yamane, Atsuhisa Tamura, Hideaki Nagai, Shinobu Akagawa, Ken Ohta	2
13	Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance treatment by antifungal triazoles 2014 ·Journal of Infection and Chemotherapy ·Kazuya Koyama, Nobuharu Ohshima, Junko Suzuki, Masahiro Kawashima, Keita Takeda, Takahiro Ando, Ryota Sato, Hideaki Nagai, Hirotoshi Matsui, Ken Ohta	30
14	[Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis]. 2008 ·PubMed ·(unknown), Naohiro Nagayama, Yoshiko Kawabe, (unknown), Junichi Suzuki, Makiko Kunogi, Yoshinori Matsui, Masahiro Kawashima, Junko Suzuki, (unknown), (unknown), Kimihiko Masuda, Hirotoshi Matsui, Hideaki Nagai, Atsuhisa Tamura, (unknown), (unknown), Kazuko Machida, Atsuyuki Kurashima, Hideki Yotsumoto	16
15	Diagnosis of Active Tuberculous Serositis by Antigen-Specific Interferon- Response of Cavity Fluid Cells 2007 ·Clinical Infectious Diseases ·Hisanori Ariga, Yoshiki Kawabe, Hiroshi Nagai, (unknown), Kimihiko Masuda, Hirotoshi Matsui, Atsuhisa Tamura, Naohiro Nagayama, Shin Akagawa, Kentaro Machida, Akira Hebisawa, Yuki Nakajima, Hideki Yotsumoto, Tatsuya Mori	38
16	Reduced Three-Dimensional Motility in Dehydrated Airway Mucus Prevents Neutrophil Capture and Killing Bacteria on Airway Epithelial Surfaces 2005 ·The Journal of Immunology ·Hirotoshi Matsui, Margrith W. Verghese, Mehmet Kesımer, Ute Schwab, Scott H. Randell, John K. Sheehan, Barbara R. Grubb, Richard C. Boucher	118
17	Topical dinitrochlorobenzene therapy in the treatment of refractory atopic dermatitis: Systemic immunotherapy☆, ☆☆ 2000 ·Journal of the American Academy of Dermatology ·Yusuke Yoshizawa, Hirotoshi Matsui, (unknown), (unknown), Howard I. Maïbach	12
18	Toxin Gene-Mediated Growth Inhibition of Lung Adenocarcinoma in an Animal Model of Pleural Malignancy 1998 ·Human Gene Therapy ·Diana K. Hoganson, Hirotoshi Matsui, Raj K. Batra, Richard C. Boucher	3
19	Detection of human T lymphotropic virus type I proviral DNA in patients with diffuse panbronchiolitis 1996 ·Respirology ·Takeshi Matsuse, Yoshinosuke Fukuchi, (unknown), Takahide Nagase, Yuji Higashimoto, Shinji Teramoto, Hirotoshi Matsui, (unknown), Kozui Kida, (unknown), Masashi Fukayama, Yasuyoshi Ouchi, Hajime Orimo	7
20	Effect of Cigarette Smoking on Pulmonary Function in Each Phenotype M of α-1-Protease Inhibitor 1995 ·CHEST Journal ·Takeshi Matsuse, Yoshinosuke Fukuchi, Hirotoshi Matsui, Eiichi Sudo, Takahide Nagase, Hajime Orimo	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact